Evaxion Biotech A/S (EVAX) Stock Forecast & Price Target $1.66 -0.19 (-10.27%) Closing price 04/1/2025 04:00 PM EasternExtended Trading$1.70 +0.04 (+2.11%) As of 04/1/2025 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Evaxion Biotech A/S - Analysts' Recommendations and Stock Price Forecast (2025) How MarketBeat Calculates Price Target and Consensus Rating MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Consensus Rating BuyBased on 2 Analyst RatingsSell0Hold0Buy2 Based on 2 Wall Street analysts who have issued ratings for Evaxion Biotech A/S in the last 12 months, the stock has a consensus rating of "Buy." Out of the 2 analysts, 2 have given a buy rating for EVAX. Consensus Price Target $10.00502.41% Upside According to the 2 analysts' twelve-month price targets for Evaxion Biotech A/S, the average price target is $10.00. The highest price target for EVAX is $14.00, while the lowest price target for EVAX is $6.00. The average price target represents a forecasted upside of 502.41% from the current price of $1.66. Get the Latest News and Ratings for EVAX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Evaxion Biotech A/S and its competitors. Enter your email to sign up for newsletter Sign Up EVAX Analyst Ratings Over TimeTypeCurrent Forecast4/2/24 to 4/2/251 Month Ago3/3/24 to 3/3/253 Months Ago1/3/24 to 1/2/251 Year Ago4/3/23 to 4/2/24Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy2 Buy rating(s)3 Buy rating(s)2 Buy rating(s)2 Buy rating(s)Hold0 Hold rating(s)0 Hold rating(s)0 Hold rating(s)0 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$10.00$20.00$55.00$55.00Forecasted Upside502.41% Upside958.20% Upside1,090.09% Upside183.51% UpsideConsensus RatingBuyBuyBuyBuy Remove Ads EVAX Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History EVAX Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Evaxion Biotech A/S Stock vs. The CompetitionTypeEvaxion Biotech A/SMedical CompaniesS&P 500Consensus Rating Score 3.00 2.82 2.54Consensus RatingBuyModerate BuyModerate BuyPredicted Upside1,104.82% Upside19,857.29% Upside19.03% UpsideNews Sentiment RatingNeutral NewsSee Recent EVAX NewsPositive NewsPositive News Remove Ads Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails2/20/2025HC Wainwright1 of 5 starsSwayampakula RamakanthSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$14.00 ➝ $14.00+449.02%2/4/2025Lake Street Capital1 of 5 starsThomas FlatenSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower TargetBuy ➝ Buy$35.00 ➝ $6.00+82.04%4/2/2024LADENBURG THALM/SH SH4 of 5 stars UpgradeNeutral ➝ Buy$40.00+143.16%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 03:55 AM ET. EVAX Forecast - Frequently Asked Questions What is Evaxion Biotech A/S's forecast for 2025? According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Evaxion Biotech A/S is $10.00, with a high forecast of $14.00 and a low forecast of $6.00. Should I buy or sell Evaxion Biotech A/S stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Evaxion Biotech A/S in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" EVAX shares. Does Evaxion Biotech A/S's stock price have much upside? According to analysts, Evaxion Biotech A/S's stock has a predicted upside of 502.41% based on their 12-month stock forecasts. What analysts cover Evaxion Biotech A/S? Evaxion Biotech A/S has been rated by research analysts at HC Wainwright, and Lake Street Capital in the past 90 days. Do Wall Street analysts like Evaxion Biotech A/S more than its competitors? Analysts like Evaxion Biotech A/S more than other "medical" companies. The consensus rating for Evaxion Biotech A/S is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how EVAX compares to other companies. Stock Forecasts and Research Tools Related Companies Acurx Pharmaceuticals Stock Forecast Talphera Stock Forecast Chromocell Therapeutics Stock Forecast AIM ImmunoTech Stock Forecast Relmada Therapeutics Stock Forecast Indaptus Therapeutics Stock Forecast Addex Therapeutics Stock Forecast Brainstorm Cell Therapeutics Stock Forecast Mainz Biomed Stock Forecast Biofrontera Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NASDAQ:EVAX) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredOil Surge Predicted... But Are You Ready?Do you own oil and gas stocks? Or are you thinking about buying some? But it's NOT oil stocks, futures, or ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evaxion Biotech A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Evaxion Biotech A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EVAX Stock Free EVAX Stock Alerts